Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial.
Headache
; 58(7): 986-992, 2018 Jul.
Article
in En
| MEDLINE
| ID: mdl-29782049
Key words
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
Database:
MEDLINE
Main subject:
Hyperacusis
/
Biomarkers
/
Tryptamines
/
Outcome Assessment, Health Care
/
Photophobia
/
Oxazolidinones
/
Serotonin 5-HT1 Receptor Agonists
/
Migraine Disorders
/
Nausea
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Guideline
Limits:
Adult
/
Humans
Language:
En
Journal:
Headache
Year:
2018
Document type:
Article